MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹444 Cr | ₹1,322 Cr | ₹4,446 Cr | ₹2,461 Cr | ₹1,780 Cr |
What is the latest Net Current Assets ratio of MANKIND PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹444 Cr |
| Mar2025 | ₹1,322 Cr |
| Mar2024 | ₹4,446 Cr |
| Mar2023 | ₹2,461 Cr |
| Mar2022 | ₹1,780 Cr |
How is Net Current Assets of MANKIND PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹444 Cr | -66.40 | |
| Mar2025 | ₹1,322 Cr | -70.26 | |
| Mar2024 | ₹4,446 Cr | 80.62 | |
| Mar2023 | ₹2,461 Cr | 38.25 | |
| Mar2022 | ₹1,780 Cr | - | |
Compare Net Current Assets of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹97,963.6 Cr | -1.2% | -7.2% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.2% |
-7.2% |
-3.5% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses